METTL3 and acute myeloid leukemia: Our study is the first to shed light on the in vivo effect of METTL3 in BMMSCs on AML progression and chemosensitivity, though it is vital to note that METTL3 appears to affect AML progression differently in AML cells and BMMSCs.